ArticleBreast cancer research and treatment2019

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer.

Jichao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.